Bifidobacterium longum CCFM1029

Bifidobacterium longum CCFM1029

Improve atopic dermatitis, Balance immunity

CHARACTERISTICS

DAILY DOSAGE IN CLINICAL STUDY

1 billion CFU for 8 weeks

SCIENTIFIC SUPPORT

HUMAN CLINICAL TRIALS

Zhifeng Fang, Hao Zhan, Jianxin Zhao, Wei Chen, Wenwei Lu. Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis, GUT MICROBES (2022)

Chinese Clinical Trial Registry (NO. ChiCTR 1900024199), ethical approval No. ET2019030, Patient recruitment inclusion criteria: Hanfin and Rajka criteria. 

Bifidobacterium longum CCFM1029

Improve atopic dermatitis, Balance immunity

Characteristics

DAILY DOSAGE IN CLINICAL STUDY

10 billion CFU for 8 weeks

Scientific support

Human clinical trial

Zhifeng Fang, Hao Zhan, Jianxin Zhao, Wei Chen, Wenwei Lu. Bifidobacterium longum mediated tryptophan metabolism to improve atopic dermatitis via the gut-skin axis, GUT MICROBES (2022)

Chinese Clinical Trial Registry (NO. ChiCTR 1900024199)，ethical approval No. ET2019030, Patient recruitment inclusion criteria: Hanfin and Rajka criteria. 

Arthur: Liu, X. Yu, L. Yu, F. Tian, J. Zhao, H. Zhang, L. Qian, Q. Wang, Z. Xue, Q. Zhai, W. Chen

  • Probiotics modulate the gut microbiota composition and immune responses in patients with atopic dermatitis: a pilot study. Springer, 2019.

Arthur: Fang, W., Lu, J., Zhao, H., Zhang, L., Qian, Q., Wang, W., Chen

Flow Chart of Study Procedure

FUNCTIONALITY

Improve the balance of Th1/Th2 immune response; Regulate intestinal flora and short chain fatty acid metabolism; Relieve inflammatory infiltration of lymphocytes in skin tissue; Effective in relieving atopic dermatitis

Why CCFM1029

  • AD is a common noninfectious skin disease with a global incidence of 20% in children and 2-8% in adults, and easy to relapse, not easy to heal.
  • AD is often treated with glucocorticoid drugs, but there are major adverse reactions.
  • Food allergy, cosmetic allergy, UV allergy, contact allergy and drug allergy can cause the occurrence of AD.

Applications

Bifidobacterium longum CCFM1029 is ideal for capsules,tablets and stick-packs.

+ More details are available upon request